Respiratory Syncytial Virus (RSV): Measuring the Impact and Vaccine Prevention Interactive Infographic

Availability

On-Demand

Course

Access expires on Jan 27, 2027

Credit Offered

No Credit Offered

There is important work to be done in raising awareness and providing education around the RSV disease state and the risks involved, especially to protect compromised groups. This interactive infographic delves into the severity of RSV, with a particular focus on patients who present with comorbidities such as COPD, asthma, and other underlying lung-related conditions.

Identify RSV pathophysiology
Describe risk factors, impact, and potential complications of RSV in older adults
Relate the importance of protecting older adults at risk for serious complications as a result of respiratory comorbidities
Prepare to implement new and emerging vaccines and illustrate their role in the prevention of RSV in adults

Supported by an independent medical educational grant from GSK

Megan Conroy, MD, MAEd, FCCPAssistant Professor of Medicine, ClinicalAssistant Program Director, Pulmonary &Critical Care FellowshipThe Ohio State UniversityColumbus, Ohio

Ryan Maves, MD, FCCPProfessor of Medicine and AnesthesiologySections of Infectious Diseases andCritical Care MedicineWake Forest University School of MedicineWinston-Salem, North Carolina

Kelly M. Pennington, MDAssistant Professor of MedicineAssistant Program Director, ALD andLung Transplant FellowshipMayo ClinicRochester, Minnesota